Palanas, Jane D.

HRN: 23-90-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/21/2023
10/27/2023
IV
285mg
OD
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: